Want to track CNTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Context Therapeutics Inc. (CNTX) Statistics
Valuation metrics
Market Cap 56.36M
Enterprise value 2.18M
Trailing P/E (ttm) -1.45
Forward P/E -
PEG ratio 0.05
Price/Sales (ttm) -
Price/Book (mrq) 1.12
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.05
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.38M
Average volume (90 days) 2.06M
Price summary
52-Week low 0.55
52-Week high 3.62
Beta -
50-Day moving average 0.69
200-Day moving average 2.22
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.68%
Return on equity -0.6%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.42
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.57
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 8.96%
Book value per share (mrq) 0.55
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
